Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events-Reference-Cited by-同舟云学术

Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events

Published:2021-02-23 Issue:4 Volume:14 Page:1338-1348
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Wigle Theodore J.¹,Povitz Brandi L.²,Medwid Samantha¹³,Teft Wendy A.³,Legan Robin M.³,Lenehan John⁴,Nevison Stephanie⁵,Panuganty Veera⁴,Keller Denise⁶,Mailloux Jaymie¹³,Siebring Victoria⁶,Sarma Sisira⁷,Choi Yun‐hee⁷,Welch Stephen⁴,Winquist Eric⁴,Schwarz Ute I.³,Kim Richard B.¹³

Affiliation:

1. Department of Physiology and Pharmacology University of Western Ontario London Canada

2. Lawson Health Research Institute London Canada

3. Department of Medicine University of Western Ontario London Canada

4. Department of Oncology University of Western Ontario London Canada

5. School of Medicine University of Toronto Mississauga Canada

6. London Health Sciences Centre London Canada

7. Department of Epidemiology and Biostatistics University of Western Ontario London Canada

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12981

Reference28 articles.

1. Hoffman‐La Roche Ltd.Xeloda (Capecitabine) Product Monograph. (2019). .

2. Hoffman‐La Rocher Ltd.Xeloda (Capecitabine) Package Insert. (2019). .

3. Sandoz Canada Inc.Fluorouracil Injection Product Monograph. (2012). .

4. Spectrum Pharmaceuticals Fluorouracil Package Insert. (2016). .

5. Safety of capecitabine: a review

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review;Therapeutic Drug Monitoring;2024-09-11

2. Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions;Drug Metabolism Reviews;2024-08-18

3. Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy;British Journal of Clinical Pharmacology;2024-07-30

4. DPYD genetic polymorphisms in non-European patients with severe fluoropyrimidine-related toxicity: a systematic review;British Journal of Cancer;2024-06-17

5. Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center;JCO Precision Oncology;2024-06